A detailed history of Horizon Kinetics Asset Management LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 11,034 shares of PACB stock, worth $18,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,034
Previous 11,517 4.19%
Holding current value
$18,757
Previous $15,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.2 - $2.17 $579 - $1,048
-483 Reduced 4.19%
11,034 $18,000
Q4 2023

Feb 15, 2024

SELL
$5.97 - $10.36 $2,883 - $5,003
-483 Reduced 4.03%
11,517 $112,000
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $81,600 - $88,800
12,000 New
12,000 $87,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $382M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Horizon Kinetics Asset Management LLC Portfolio

Follow Horizon Kinetics Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.